Navellier & Associates’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,025
Closed -$259K 286
2022
Q3
$259K Sell
5,025
-50
-1% -$2.97K 0.06% 230
2022
Q2
$267K Sell
5,075
-2
-0% -$139 0.06% 243
2022
Q1
$436K Sell
5,077
-852
-14% -$70K 0.07% 216
2021
Q4
$484K Buy
+5,929
New +$433K 0.07% 212

Other funds holding THC

Navellier & Associates's THC Position: Q4 2022 in Review

Navellier & Associates sold out of Tenet Healthcare (THC) in Q4 2022, closing a stake of 5,025 shares — an estimated $259K sold.

Navellier & Associates first reported a position in THC in Q4 2021 and held it in 4 quarters. The position peaked at $484K in Q4 2021. 354 funds tracked by Wall St. Rank hold THC as of Q4 2022.

  • Navellier & Associates reported no remaining Tenet Healthcare position as of Q4 2022 after selling out during the quarter.
  • Navellier & Associates sold 5,025 Tenet Healthcare shares in Q4 2022, an estimated $259K.
  • Navellier & Associates first reported a position in Tenet Healthcare in Q4 2021 and held it in 4 quarters.
  • Navellier & Associates's Tenet Healthcare position peaked at $484K in Q4 2021.
  • 354 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2022.

Based on Navellier & Associates's 13F filing for Q4 2022, filed 2 Feb 2023.